MENU
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genmab A/S ADS (GMAB) Ownership - Who owns Genmab A/S ADS?
Profile
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.38B
P/E Ratio
20.82
Total Cash
17.32B
Projected Growth
0.75
Total Debt
987M
Revenue
19.84B
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
27.26
Total Debt/Equity
N/A
Revenue/Share
4.21 USD as % of share price
Fundamentals
GMAB
Capitalization
13.4B
P/E Ratio
20.82
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash
17.3B
Total Cash/Share
27.26
Total Debt
987M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.75
Revenue/Share (as % of the share price)
4.21%
Revenue
19.8B
ROE
N/A
Book Value
31.9B
P/B Ratio
3.00
Cash Flow
N/A
Earnings
7.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66M
Current Ratio
5.17
Current Revenue Per Employee
2193190.80
Dividends Per Share - Security
N/A
EBITDA
6.97B
Float
N/A
Float - Current
N/A
Gross Income Margin
95.07
Revenue To Assets
12.56
Shares Held By Institutions
19.5B
Shares Outstanding - Current
635M
Total Liabilities
7.74B
Total Volume MTD
N/A
Value
-1
Gain YTD
-0.335
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com